Quality Control (QC) and Quality Assurance (QA) Experts ensure that pharmaceutical products meet the required safety, efficacy, and regulatory standards throughout the production process. QC experts focus on testing raw materials, in-process materials, and finished products to identify any defects or deviations from specifications. Their work involves performing a range of tests, including chemical, physical, and microbiological analyses, to ensure that each batch of drugs is safe for use. By monitoring each stage of production, QC experts help prevent substandard products from reaching consumers. They also identify and address any production inefficiencies that could impact product quality and consistency. Their attention to detail ensures that even minor deviations are promptly addressed to maintain product integrity and consumer trust.
QA experts, on the other hand, focus on the overall system, ensuring that manufacturing processes, procedures, and documentation comply with regulatory requirements such as Good Manufacturing Practices (GMP). They play a key role in reviewing production processes, conducting audits, and ensuring that any potential risks are identified and mitigated. These experts also collaborate with regulatory agencies and internal teams to ensure that all products are produced in compliance with safety standards and industry regulations. By maintaining stringent quality standards, QA and QC experts safeguard public health and contribute to the successful approval and marketing of pharmaceutical products.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia